首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3404篇
  免费   265篇
  国内免费   18篇
耳鼻咽喉   17篇
儿科学   120篇
妇产科学   155篇
基础医学   461篇
口腔科学   50篇
临床医学   304篇
内科学   657篇
皮肤病学   15篇
神经病学   574篇
特种医学   231篇
外科学   405篇
综合类   71篇
一般理论   1篇
预防医学   199篇
眼科学   68篇
药学   176篇
肿瘤学   183篇
  2021年   48篇
  2017年   33篇
  2016年   39篇
  2015年   46篇
  2014年   63篇
  2013年   83篇
  2012年   99篇
  2011年   122篇
  2010年   68篇
  2009年   51篇
  2008年   129篇
  2007年   121篇
  2006年   166篇
  2005年   140篇
  2004年   126篇
  2003年   123篇
  2002年   110篇
  2001年   103篇
  2000年   114篇
  1999年   111篇
  1998年   56篇
  1997年   50篇
  1996年   57篇
  1995年   53篇
  1994年   41篇
  1993年   29篇
  1992年   110篇
  1991年   93篇
  1990年   94篇
  1989年   82篇
  1988年   72篇
  1987年   73篇
  1986年   72篇
  1985年   66篇
  1984年   58篇
  1983年   52篇
  1982年   41篇
  1980年   38篇
  1979年   60篇
  1978年   45篇
  1977年   36篇
  1976年   47篇
  1975年   38篇
  1974年   46篇
  1973年   42篇
  1972年   31篇
  1971年   35篇
  1970年   40篇
  1969年   31篇
  1968年   29篇
排序方式: 共有3687条查询结果,搜索用时 31 毫秒
1.
Animal and human studies suggest fish oil and green tea may have protective effect on prostate cancer. Fatty acid synthase (FAS) has been hypothesized to be linked to chemoprotective effects of both compounds. This study evaluated the independent and joint effects of fish oil (FO) and green tea supplement (epigallocatechin-3-gallate, EGCG) on FAS and Ki-67 levels in prostate tissue. Through a double-blinded, randomized controlled trial with 2 × 2 factorial design, 89 men scheduled for repeat prostate biopsy following an initial negative prostate biopsy were randomized into either FO alone (1.9 g DHA + EPA/day), EGCG alone (600 mg/day), a combination of FO and EGCG, or placebo. We used linear mixed-effects models to test the differences of prostate tissue FAS and Ki-67 by immunohistochemistry between pre- and post-intervention within each group, as well as between treatment groups. Results did not show significant difference among treatment groups in pre-to-post-intervention changes of FAS (P = 0.69) or Ki-67 (P = 0.26). Comparing placebo group with any of the treatment groups, we did not find significant difference in FAS or Ki-67 changes (all P > 0.05). Results indicate FO or EGCG supplementation for a short duration may not be sufficient to produce biologically meaningful changes in FAS or Ki-67 levels in prostate tissue.  相似文献   
2.
BACKGROUND: Few data are currently available investigating neurosteroids (NS) in Alzheimer's disease (AD). The NS allopregnanolone may be decreased in serum and plasma in patients with AD, but it is unclear if allopregnanolone is also reduced in brain. Because a number of NS exhibit neuroprotective effects and impact cognitive performance in rodent models, these molecules may be relevant to the pathophysiology of neurodegenerative disorders. We therefore investigated prefrontal cortex (PFC) NS levels in AD. METHODS: Neurosteroid levels (allopregnanolone, pregnenolone, dehydroepiandrosterone [DHEA]) were determined in postmortem PFC in 14 male subjects with AD and 15 cognitively intact male control subjects by gas chromatography/mass spectrometry preceded by high-performance liquid chromatography purification. RESULTS: Subjects with AD exhibit significant reductions in allopregnanolone compared with cognitively intact control subjects (median levels = 2.50 ng/g vs. 5.59 ng/g, respectively; p = .02). Allopregnanolone levels are inversely correlated with neuropathological disease stage (Braak), r = -.49, p = .007. Median DHEA levels are elevated in subjects with AD (p = .01). CONCLUSIONS: Subjects with AD demonstrate significant reductions in PFC allopregnanolone levels, a finding that may be relevant to neuropathological disease stage severity. Neurosteroids may have utility as candidate biomarkers in AD.  相似文献   
3.
4.
Pseudomonas aeruginosa ribosomal vaccines were tested for their ability to protect rats subjected to a 20% total body surface burn against the lethal effects of infection with homologous organisms. When administered prior to burning, the vaccines provided 100% protection. When administered postburning, the vaccine from one strain also provided 100% protection when the time interval between vaccination and infection was 3 days. When this time interval was reduced to 1 or 2 days, approximately 50% protection was obtained with the same vaccine. The vaccine from a second strain tested provided about 50% protection with a 3-day time interval. In addition, passive immunization using antiserum to a ribosomal vaccine was also demonstrated to be effective in protecting burned and infected rats, especially when multiple doses of antiserum were used. In this case, 80% protection was obtained (with no protection observed using multiple doses of normal serum). Finally, a comparison of ribosomal and lipopolysaccharide vaccines and antisera was also performed.  相似文献   
5.
6.
7.
Follow up MRI study in first episode schizophrenia.   总被引:2,自引:0,他引:2  
  相似文献   
8.
N-acetylcysteine as an antidote in methylmercury poisoning.   总被引:1,自引:0,他引:1       下载免费PDF全文
Methylmercury is a ubiquitous environmental pollutant and potent neurotoxin. Treatment of methylmercury poisoning relies almost exclusively on the use of chelating agents to accelerate excretion of the metal. The present study demonstrates that oral administration of N-acetylcysteine (NAC), a widely available and largely nontoxic amino acid derivative, produces a profound acceleration of urinary methylmercury excretion in mice. Mice that received NAC in the drinking water (10 mg/ml) starting at 48 hr after methylmercury administration excreted from 47 to 54% of the 203Hg in urine over the subsequent 48 hr, as compared to 4-10% excretion in control animals. When NAC-containing water was given from the time of methylmercury administration, it was even more effective at enhancing urinary methylmercury excretion and at lowering tissue mercury levels. In contrast, excretion of inorganic mercury was not affected by oral NAC administration. The ability of NAC to enhance methylmercury excretion when given orally, its relatively low toxicity, and is wide availability in the clinical setting indicate that it may be an ideal therapeutic agent for use in methylmercury poisoning.  相似文献   
9.
The cognitive dimension of mental energy can be assessed by tests of vigilance and choice reaction time. These behaviors are relatively simple cognitive functions and can be measured with precision and reliability if carefully designed and implemented tests are used. Because the concept of mental energy is still evolving, the selection of appropriate tests to assess it must be tentative. However, vigilance and choice reaction time seem to have the necessary psychometric properties for assessing mental energy, including construct, predictive content, and face validity. Tests of reaction time and vigilance are correlated with questionnaires that measure mood states corresponding to mental energy—such as sleepiness, fatigue, and alertness—in the expected manner and are of approximately equivalent sensitivity.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号